KALV: KalVista Pharmaceuticals Company Short-Term Debt
The market trend for KalVista Pharmaceuticals (KALV) visualized in monetary format on the GURU.Markets platform, where the indicator stands at 0.00, is based on future sales of tablet-based treatments for hereditary angioedema. The emerging oral treatment infrastructure replaces injections, establishing itself as the therapeutic gold standard. Business resilience is ensured by the retention of key scientists and the recruitment of experts in global drug commercialization.
Metric breakdowns and analytics for KalVista Corp (KALV)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital KalVista Pharmaceuticals|KALV - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity KalVista Pharmaceuticals|KALV - Company Total Debt|Debt to Book Capitalization Ratio KalVista Pharmaceuticals, Inc.|KALV - Company Long-Term Liabilities|Company Current Liabilities KalVista Pharmaceuticals|Quick Liquidity kalvista.com
- net income and valuation multiples indicators:
Initial company analysis:KALV - KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals (KALV) is transitioning to the commercialization stage of its first drug, which necessitates precise liquidity management. This metric aggregates all obligations maturing within one year, reflecting the current credit load. It is critical for investors to benchmark this data against the WACC to distinguish strategic growth leverage from insolvency risk. Analyzing total short-term liabilities allows for an assessment of the company's resilience prior to the sales launch. The trend of these obligations reveals the efficiency of operating cash flow utilization.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB - Company Short-Term Debt|ZBIO - Company Short-Term Debts|IMNM: Company Short-Term Debts|gossamerbio.com (GOSS) - Company Short-Term Debts|Company Short-Term Debt Septerna|Company Short-Term Debt PVLA|Company Current Liabilities SVRA (Savara Corp)|Company Short-Term Debt RIGL (Rigel Corp)|Company Short-Term Debts ANAB (AnaptysBio, Inc.)|Short-Term Debt Volume astriatx.com (ATXS)|ENGN - Company Short-Term Debt|Short-Term Debt Volume rapt.com RAPT|JBIO (aerovatetx.com) - Company Current Liabilities|ACRS: Amount of Current Liabilities|KYTX (Kyverna Therapeutics) - Company Short-Term Debts|Company Short-Term Debts tizianalifesciences.com|Company Current Liabilities CABA (Cabaletta Bio)|VTYX (Ventyx Biosciences Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Theratechnologies Inc THTX|AVTX (Avalo Therapeutics Inc) - Current Liabilities|Eledon Pharmaceuticals - Company Short-Term Debts|Company Short-Term Loans and Borrowings AGEN (agenusbio.com)|CLYM: Company Short-Term Debts|zurabio.com (ZURA) - Company Short-Term Debts|Company Short-Term Debt aTyr|ADAG: Company Short-Term Loans and Borrowings|Company Short-Term Debt ImageneBio Inc (IMA)|Company Current Liabilities shattucklabs.com STTK|Company Short-Term Debts EQ (Equillium)|Company Short-Term Debts Connect Biopharma Holdings CNTB|Immunic Inc - Company Short-Term Debts|Atara Biotherapeutics (ATRA) - Company Current Liabilities|IFRX: Company Short-Term Debts|Short-Term Debt x4pharma.com (XFOR)|Company Current Liabilities ACET|Company Short-Term Debts Celularity Corp|Company Current Liabilities INMB (INmune Bio Corp)|Amount of Current Liabilities BRNS|Company Short-Term Debts KZR (Kezar Life Sciences)|Short-Term Debt Volume sabbiotherapeutics.com (SABS)|Akari Therapeutics Plc - Company Short-Term Debts|Enlivex Therapeutics (ENLV) - Company Current Liabilities|QTTB: Company Short-Term Debts|GeoVax Corp (GOVX) - Company Short-Term Debts|Company Short-Term Debt Edesa Biotech, Inc.|Company Short-Term Debt IBIO|Company Short-Term Debt Carisma Therapeutics (CARM)|Short-Term Debt Volume XTL Biopharmaceuticals Ltd|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|Company Short-Term Debts HCW Biologics, Inc. HCWB|Aptevo - Company Short-Term Debts|AIM - Company Short-Term Debts|aditxt.com (ADTX) - Company Short-Term Debt|GRI (GRI Bio Inc) - Company Short-Term Debt|Company Current Liabilities XRTX|Company Short-Term Debt HIND|Company Short-Term Debt Revelation Biosciences (REVB)|INDP: Current Liabilities|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Company Short-Term Loans and Borrowings CALI|Affimed Therapeutics - Company Short-Term Debts|ALLK - Company Short-Term Debts|hookipapharma.com (HOOK) - Company Short-Term Debt|IGM Biosciences - Company Short-Term Loans and Borrowings|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Short-Term Debts TCBP|Company Short-Term Debts Third Harmonic Bio Inc (THRD)